| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.931 | 11.052 | - | 10.689 | - | - | - | - | - | 9.541 |
| Total Income - EUR | 27.931 | 11.052 | - | 29.002 | - | - | - | - | - | 9.541 |
| Total Expenses - EUR | 33.622 | 23.152 | - | 15.493 | - | - | - | - | - | 14.359 |
| Gross Profit/Loss - EUR | -5.692 | -12.100 | - | 13.509 | - | - | - | - | - | -4.818 |
| Net Profit/Loss - EUR | -6.530 | -12.343 | - | 12.925 | - | - | - | - | - | -4.839 |
| Employees | 1 | 1 | - | 1 | - | - | - | - | - | 1 |
Check the financial reports for the company - Bebecris Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.363 | 18.727 | - | 2.710 | - | - | - | - | - | 5.629 |
| Current Assets | 3.685 | 8.418 | - | 17.169 | - | - | - | - | - | 3.097 |
| Inventories | 0 | 0 | - | 782 | - | - | - | - | - | 0 |
| Receivables | 545 | 1.459 | - | 601 | - | - | - | - | - | 142 |
| Cash | 3.140 | 6.959 | - | 15.786 | - | - | - | - | - | 2.954 |
| Shareholders Funds | 7.368 | -18.667 | - | -24.148 | - | - | - | - | - | -45.955 |
| Social Capital | 112 | 111 | - | 107 | - | - | - | - | - | 101 |
| Debts | 26.680 | 45.812 | - | 44.028 | - | - | - | - | - | 54.681 |
| Income in Advance | 0 | 0 | - | 0 | - | - | - | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bebecris Med Srl